E86-24334-92764 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-08-02
Dose 1 — Moderna
2022-08-05
Registered in v-safe
2022-08-05
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Fair · Sleepiness, Irritability/crying, Rash, not including the immediate area around the injection site

Under 3 check-in
2022-08-09
Health check-in — day 7, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-08-16
Health check-in — day 14, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-08-25
Health check-in — day 21, dose 1, under 3
Feeling: Good

Under 3 check-in
2022-08-30
Dose 2 — Moderna
2022-08-30
Health check-in — day 0, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-08-31
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-09-01
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-09-02
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · Sleepiness

Under 3 check-in
2022-09-04
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-09-05
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-09-08
Health check-in — day 7, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-09-13
Health check-in — day 14, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-09-20
Health check-in — day 21, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-09-27
Survey response — day 28, dose 2, under 3
MedDRA: Cough, Nasopharyngitis, Respiratory tract congestion, Sneezing — Feeling: Fair · Be unable to work or attend school

Free text: Cold symptoms (congestion, coughing, sneezing)

MedDRA releases: 2024-11 · check-in free text available
2022-10-05
Survey response — day 35, dose 2, under 3
MedDRA: Cough, Rhinorrhoea — Feeling: Good · Be unable to work or attend school

Free text: Cough, runny nose

MedDRA releases: 2024-11 · check-in free text available
2022-12-01
Survey response — 3 months, dose 2, under 3
MedDRA: Cough, Decreased appetite, Ear pain, Fatigue, Malaise, Nasal congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Nasal congestion, cough, decreased appetite, fatigue, malaise, ear pain

MedDRA releases: 2024-11 · check-in free text available
2023-02-28
Survey response — 6 months, dose 2, under 3
MedDRA: Cough, Influenza, Nasopharyngitis, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities

MedDRA releases: 2024-11

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-08-02	Moderna	No
2	2022-08-30	Moderna	No

Free text

Release 12 (Under 3) — day 28, dose 2, under 3

2022-09-27

Symptoms: Cold symptoms (congestion, coughing, sneezing)

Release 12 (Under 3) — day 35, dose 2, under 3

2022-10-05

Symptoms: Cough, runny nose

Release 12 (Under 3) — 3 months, dose 2, under 3

2022-12-01

Symptoms: Nasal congestion, cough, decreased appetite, fatigue, malaise, ear pain

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Decreased appetite	·	·	✓
SD	Ear pain	·	·	✓
SD	Fatigue	·	·	✓
SD	Influenza	·	·	✓
SD	Malaise	·	·	✓
SD	Nasal congestion	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SD	Rhinorrhoea	·	·	✓
SD	Sneezing	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release